Acute Myocardial Infarction
544
38
54
297
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
38 trials with published results (7%)
Research Maturity
297 completed trials (55% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.3%
29 terminated out of 544 trials
91.1%
+4.6% vs benchmark
19%
106 trials in Phase 3/4
13%
38 of 297 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 297 completed trials
Clinical Trials (544)
A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Heart Attack
MERITnI - Mindray-hs-cTnI Assay: Analytical and Clinical Evaluation for the Diagnosis and RIsk AssessmenT of Myocardial InfarctIon.
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction
Pericardial Effusion From Acute Myocardial Infarction: Contributing Factors and Prognosis at One Year (EPERICARDIM)
Iron Deficiency in Acute Myocardial Infarction: Prevalence Pilot Study
Arrhythmia Detection After MI
Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.
UC-MSC Transplantation for Left Ventricular Dysfunction After AMI
Improving Cardiac Rehabilitation Outcomes Through Mobile Case Management (iCARE)
Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention
Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock
STEMI Cool Pilot Trial to Assess Cooling as an Adjunctive Therapy to PCI In Patients With Acute MI (Phase A)
Acute Myocardial Infarction Clinical Cohort
SUBDIMA: Subclinical Depression in Acute Myocardial Infarction (SUBDIMA25)
Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
Ticagrelor Monotherapy After Stenting
EXCELLENT (EXpanded CELL ENdocardiac Transplantation)
BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction
New-Onset Atrial Fibrillation Complicating Acute Myocardial Infarction in China
Antiplatelets and Intramyocardial Hemorrhage in STEMI: Incidence and Outcomes